findmyKOL
Clinical trialNCT02494388TerminatedObservational

Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions

SponsorUniversity of Medicine and Pharmacy CraiovaEnrollment10CystadenocarcinomaIntraductal Papillary Mucinous NeoplasmPancreatic CystsPancreatic Mucinous-Cystic NeoplasmSerous CystadenomaSolid Pseudopapillary Tumour of the Pancreas
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study is based on a multi-center approach of needle based confocal laser endomicroscopy (nCLE) combined with endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration (FNA) to evaluate pancreatic cystic lesions (PCL), in order to obtain a correct histopathological diagnosis.After detection of PCL, certain morphological EUS features allow the discrimination of specific cyst types. Additionally, EUS-FNA is recommended as the first-line procedure whenever pathological diagnosis is required; however the procedure has its drawbacks, mainly represented by the relatively low negative predictive value in diagnosing pancreatic cancer. In this case a more precisely diagnostic tool is required; the potential role of CLE has been explored in gastrointestinal (GI) pathology showing good accuracy for predicting the final histopathological diagnosis based on immediate evaluation of tissue and vascular patterns. Although the clinical impact of nCLE for the decision making algorithms in cystic pancreatic neoplasm has not yet been described, the hypothesis is that EUS-nCLE could allow targeted tissue sampling of cystic pancreatic neoplasms resulting in more accurate diagnosis. The aim of the study is to describe the clinical impact of nCLE for the clinical decision management algorithm based on EUS, EUS-FNA and/or EUS-CLE imaging criteria for cystic pancreatic neoplasms, while evaluating also the feasibility and safety of nCLE examination.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Denmark
  • Copenhagen University Hospital at Herlev

    Copenhagen, Denmark

Romania
  • Research Center of Gastroenterology and Hepatology

    Craiova, Romania

United Kingdom
  • University College London Hospitals

    London, England, United Kingdom

United States
  • Ochsner Medical Center

    New Orleans, Louisiana, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • New York Presbyterian Hospital

    New York, New York, United States

  • Jefferson Medical College of Thomas Jefferson University

    Philadelphia, Pennsylvania, United States

  • the University of Texas Md Anderson Cancer Center

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2015
Primary completion
30 Jun 2017
Completion
30 Jun 2017
Last update posted
17 Jan 2018
Registered enrollment
10
Registry id
NCT02494388

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 30 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.